Five Below, Inc (FIVE) stock
FIVENasdaqRetail-Variety StoresFiscal year ends January 30
Financials through Q2 FY2026, quarter ended Aug 1, 2026Last filing: 10-Q on Sep 3, 2026Score 21/3017% below fair value
$240.96−4.54 (-1.85%)
Close on Oct 30, 2026Market cap $13.27BP/E 21.6Yield –
Earnings
Five Below's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Dec 2, 2026
Q3 FY2026 · estimated, after the close
Revenue, Q2 FY2026
$1.26B
+22.7% on a year earlier
Adjusted diluted income per common share, Q2 FY2026
$1.68
$0.81 a year earlier
Latest guidance
Raised
Jun 3, 2026 · 13 items
Quarterly results
Revenue and earnings per share from each of Five Below's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2026ended Nov 1, 2026 | Dec 2, 2026Expected | – | – | – | – | – |
| Q2 FY2026ended Aug 1, 2026 | Sep 2, 2026after the close | $1.26B | +22.7% | $3.99 | $1.68 | Release |
| Q1 FY2026ended May 2, 2026 | Jun 3, 2026after the close | $1.29B | +32.5% | $2.21 | $2.22 | Release |
| Q4 FY2025ended Jan 31, 2026 | Mar 18, 2026after the close | $1.73B | +24.5% | $4.28 | $4.31 | Release |
| Q3 FY2025ended Nov 1, 2025 | Dec 3, 2025after the close | $1.04B | +23.1% | $0.66 | $0.68 | Release |
| Q2 FY2025ended Aug 2, 2025 | Aug 27, 2025after the close | $1.03B | +23.7% | $0.77 | $0.81 | Release |
| Q1 FY2025ended May 3, 2025 | Jun 4, 2025after the close | $970.50M | +19.5% | $0.75 | $0.86 | Release |
| Q4 FY2024ended Feb 1, 2025 | Mar 19, 2025after the close | $1.39B | +3.7% | $3.39 | $3.48 | Release |
| Q3 FY2024ended Nov 2, 2024 | Dec 4, 2024after the close | $843.70M | +14.6% | $0.03 | $0.42 | Release |
| Q2 FY2024ended Aug 3, 2024 | Aug 28, 2024after the close | $830.10M | +9.4% | $0.60 | $0.54 | Release |
| Q1 FY2024ended May 4, 2024 | Jun 5, 2024after the close | $811.90M | +11.8% | $0.57 | $0.60 | Release |
| Q4 FY2023ended Feb 3, 2024 | Mar 20, 2024after the close | $1.34B | +19.3% | $3.65 | – | Release |
| Q3 FY2023ended Oct 28, 2023 | Nov 29, 2023after the close | $736.40M | +14.2% | $0.26 | – | Release |
| Q2 FY2023ended Jul 29, 2023 | Aug 30, 2023after the close | $759.00M | +13.5% | $0.84 | – | Release |
| Q1 FY2023ended Apr 29, 2023 | Jun 1, 2023after the close | $726.20M | +13.5% | $0.67 | – | Release |
| Q4 FY2022ended Jan 28, 2023 | Mar 15, 2023after the close | $1.12B | +12.7% | $3.07 | – | Release |
| Q3 FY2022ended Oct 29, 2022 | Nov 30, 2022after the close | $645.00M | +6.2% | $0.29 | – | Release |
| Q2 FY2022ended Jul 30, 2022 | Aug 31, 2022after the close | $668.90M | – | $0.74 | – | Release |
| Q1 FY2022ended Apr 30, 2022 | Jun 8, 2022after the close | $639.60M | – | $0.59 | – | Release |
| Q4 FY2021ended Jan 29, 2022 | Mar 30, 2022before the open | $996.30M | – | $2.49 | – | Release |
| Q3 FY2021ended Oct 30, 2021 | Dec 1, 2021after the close | $607.60M | – | $0.43 | – | Release |
| Q2 FY2021ended Jul 31, 2021 | Sep 1, 2021after the close | – | – | – | – | Filing |
| Q1 FY2021ended May 1, 2021 | Jun 3, 2021after the close | – | – | – | – | Filing |
| Q4 FY2020ended Jan 30, 2021 | Mar 17, 2021after the close | – | – | – | – | Filing |
| Q3 FY2020ended Oct 31, 2020 | Dec 2, 2020after the close | – | – | – | – | Filing |
| Q2 FY2020ended Aug 1, 2020 | Sep 2, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Five Below's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net sales | FY2026 | $5.40B – $5.48B | $5.20B – $5.30B | Raised | Jun 3, 2026 |
| comparable sales | FY2026 | +6% – +8% | +3% – +5% | Raised | Jun 3, 2026 |
| Diluted income per common shareGAAP | FY2026 | $8.62 – $9.02 | $7.69 – $8.20 | Raised | Jun 3, 2026 |
| Adjusted diluted income per common sharenon-GAAP | FY2026 | $8.65 – $9.05 | $7.74 – $8.25 | Raised | Jun 3, 2026 |
| Gross capital expenditures | FY2026 | $230.00M – $250.00M | $230.00M – $250.00M | Reaffirmed | Jun 3, 2026 |
| Adjusted net incomenon-GAAP | FY2026 | $482.00M – $504.00M | $431.00M – $459.00M | Raised | Jun 3, 2026 |
| Net incomeGAAP | FY2026 | $480.00M – $502.00M | $429.00M – $457.00M | Raised | Jun 3, 2026 |
Guidance vs results
The last range Five Below gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q2 FY2026 | Adjusted diluted income per common share | $1.17 – $1.29 | $1.68 | Above range |
| Q2 FY2026 | EPS (GAAP) | $1.15 – $1.27 | $3.99 | Above range |
| Q2 FY2026 | Revenue | $1.18B – $1.20B | $1.26B | Above range |
| Q1 FY2026 | Adjusted diluted income per common share | $1.57 – $1.69 | $2.22 | Above range |
| Q1 FY2026 | EPS (GAAP) | $1.55 – $1.67 | $2.21 | Above range |
| Q1 FY2026 | Revenue | $1.18B – $1.20B | $1.29B | Above range |
| FY2025 | Adjusted diluted income per common share | $5.71 – $5.89 | $6.66Σ4Q | Above range |
| FY2025 | EPS (GAAP) | $5.51 – $5.69 | $6.46Σ4Q | Above range |
| FY2025 | Revenue | $4.62B – $4.65B | $4.77BΣ4Q | Above range |
| Q4 FY2025 | Adjusted diluted income per common share | $3.36 – $3.54 | $4.31 | Above range |
| Q4 FY2025 | EPS (GAAP) | $3.34 – $3.52 | $4.28 | Above range |
| Q4 FY2025 | Revenue | $1.58B – $1.61B | $1.73B | Above range |
| Q3 FY2025 | Adjusted diluted income per common share | $0.12 – $0.24 | $0.68 | Above range |
| Q3 FY2025 | EPS (GAAP) | $0.09 – $0.21 | $0.66 | Above range |
| Q3 FY2025 | Revenue | $950.00M – $970.00M | $1.04B | Above range |
| Q2 FY2025 | Adjusted diluted income per common share | $0.50 – $0.62 | $0.81 | Above range |
| Q2 FY2025 | EPS (GAAP) | $0.45 – $0.57 | $0.77 | Above range |
| Q2 FY2025 | Revenue | $975.00M – $995.00M | $1.03B | Above range |
| Q1 FY2025 | Adjusted diluted income per common share | $0.50 – $0.61 | $0.86 | Above range |
| Q1 FY2025 | EPS (GAAP) | $0.44 – $0.55 | $0.75 | Above range |
| Q1 FY2025 | Revenue | $905.00M – $925.00M | $970.50M | Above range |
| Q4 FY2024 | Adjusted diluted income per common share | $3.23 – $3.41 | $3.48 | Above range |
| Q4 FY2024 | EPS (GAAP) | $3.15 – $3.33 | $3.39 | Above range |
| Q4 FY2024 | Revenue | $1.35B – $1.38B | $1.39B | Above range |
| Q3 FY2024 | Adjusted diluted income per common share | $0.10 – $0.22 | $0.42 | Above range |
| Q3 FY2024 | EPS (GAAP) | $0.04 – $0.24 | $0.03 | Below range |
| Q3 FY2024 | Revenue | $780.00M – $800.00M | $843.70M | Above range |
| Q2 FY2024 | EPS (GAAP) | $0.57 – $0.69 | $0.60 | Within range |
| Q2 FY2024 | Revenue | $830.00M – $850.00M | $830.10M | Within range |
| Q1 FY2024 | EPS (GAAP) | $0.58 – $0.69 | $0.57 | Below range |
| Q1 FY2024 | Revenue | $826.00M – $846.00M | $811.90M | Below range |
| Q4 FY2023 | EPS (GAAP) | $3.64 – $3.80 | $3.65 | Within range |
| Q4 FY2023 | Revenue | $1.32B – $1.35B | $1.34B | Within range |
| Q3 FY2023 | EPS (GAAP) | $0.17 – $0.25 | $0.26 | Above range |
| Q3 FY2023 | Revenue | $715.00M – $730.00M | $736.40M | Above range |
| Q2 FY2023 | EPS (GAAP) | $0.80 – $0.85 | $0.84 | Within range |
| Q2 FY2023 | Revenue | $755.00M – $765.00M | $759.00M | Within range |
| Q1 FY2023 | EPS (GAAP) | $0.59 – $0.65 | $0.67 | Above range |
| Q1 FY2023 | Revenue | $723.00M – $735.00M | $726.20M | Within range |
| Q4 FY2022 | EPS (GAAP) | $2.93 – $3.09 | $3.07 | Within range |
| Q4 FY2022 | Revenue | $1.09B – $1.11B | $1.12B | Above range |
| Q3 FY2022 | EPS (GAAP) | $0.08 – $0.19 | $0.29 | Above range |
| Q3 FY2022 | Revenue | $600.00M – $619.00M | $645.00M | Above range |
| Q2 FY2022 | EPS (GAAP) | $0.74 – $0.86 | $0.74 | Within range |
| Q2 FY2022 | Revenue | $675.00M – $695.00M | $668.90M | Below range |
| Q1 FY2022 | EPS (GAAP) | $0.54 – $0.62 | $0.59 | Within range |
| Q1 FY2022 | Revenue | $644.00M – $658.00M | $639.60M | Below range |
| Q4 FY2021 | EPS (GAAP) | $2.36 – $2.48 | $2.49 | Above range |
| Q4 FY2021 | Revenue | $985.00M – $1.01B | $996.30M | Within range |
Guidance history
Every forecast Five Below put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Jun 3, 2026 | Gross capital expenditures | FY2026 | $230.00M – $250.00M | Reaffirmed |
| Jun 3, 2026 | comparable sales | FY2026 | +6% – +8% | Raised |
| Jun 3, 2026 | comparable sales | Q2 FY2026 | +7% – +9% | New |
| Jun 3, 2026 | Adjusted diluted income per common share | FY2026 | $8.65 – $9.05 | Raised |
| Jun 3, 2026 | Adjusted diluted income per common share | Q2 FY2026 | $1.17 – $1.29 | New |
| Jun 3, 2026 | Diluted income per common share | FY2026 | $8.62 – $9.02 | Raised |
| Jun 3, 2026 | Diluted income per common share | Q2 FY2026 | $1.15 – $1.27 | New |
| Jun 3, 2026 | Net income | FY2026 | $480.00M – $502.00M | Raised |
| Jun 3, 2026 | Adjusted net income | FY2026 | $482.00M – $504.00M | Raised |
| Jun 3, 2026 | Net income | Q2 FY2026 | $64.00M – $71.00M | New |
| Jun 3, 2026 | Adjusted net income | Q2 FY2026 | $65.00M – $72.00M | New |
| Jun 3, 2026 | Net sales | FY2026 | $5.40B – $5.48B | Raised |
| Jun 3, 2026 | Net sales | Q2 FY2026 | $1.18B – $1.20B | New |
| Mar 18, 2026 | Gross capital expenditures | FY2026 | $230.00M – $250.00M | New |
| Mar 18, 2026 | comparable sales | FY2026 | +3% – +5% | New |
| Mar 18, 2026 | comparable sales | Q1 FY2026 | +14% – +16% | New |
| Mar 18, 2026 | Adjusted diluted income per common share | FY2026 | $7.74 – $8.25 | New |
| Mar 18, 2026 | Adjusted diluted income per common share | Q1 FY2026 | $1.57 – $1.69 | New |
| Mar 18, 2026 | Diluted income per common share | FY2026 | $7.69 – $8.20 | New |
| Mar 18, 2026 | Diluted income per common share | Q1 FY2026 | $1.55 – $1.67 | New |
| Mar 18, 2026 | Net income | FY2026 | $429.00M – $457.00M | New |
| Mar 18, 2026 | Adjusted net income | FY2026 | $431.00M – $459.00M | New |
| Mar 18, 2026 | Net income | Q1 FY2026 | $86.00M – $93.00M | New |
| Mar 18, 2026 | Adjusted net income | Q1 FY2026 | $88.00M – $94.00M | New |
| Mar 18, 2026 | Net sales | FY2026 | $5.20B – $5.30B | New |
| Mar 18, 2026 | Net sales | Q1 FY2026 | $1.18B – $1.20B | New |
| Dec 3, 2025 | Gross capital expenditures | FY2025 | $200.00M | New |
| Dec 3, 2025 | comparable sales | FY2025 | +9.4% – +10.1% | New |
| Dec 3, 2025 | comparable sales | Q4 FY2025 | +6% – +8% | New |
| Dec 3, 2025 | Adjusted diluted income per common share | FY2025 | $5.71 – $5.89 | New |
| Dec 3, 2025 | Adjusted diluted income per common share | Q4 FY2025 | $3.36 – $3.54 | New |
| Dec 3, 2025 | Diluted income per common share | FY2025 | $5.51 – $5.69 | New |
| Dec 3, 2025 | Diluted income per common share | Q4 FY2025 | $3.34 – $3.52 | New |
| Dec 3, 2025 | Net income | FY2025 | $306.00M – $316.00M | New |
| Dec 3, 2025 | Adjusted net income | FY2025 | $317.00M – $327.00M | New |
| Dec 3, 2025 | Net income | Q4 FY2025 | $186.00M – $196.00M | New |
| Dec 3, 2025 | Adjusted net income | Q4 FY2025 | $187.00M – $197.00M | New |
| Dec 3, 2025 | Net sales | FY2025 | $4.62B – $4.65B | New |
| Dec 3, 2025 | Net sales | Q4 FY2025 | $1.58B – $1.61B | New |
| Aug 27, 2025 | Gross capital expenditures | FY2025 | $210.00M | Lowered |
| Aug 27, 2025 | comparable sales | Q3 FY2025 | +5% – +7% | New |
| Aug 27, 2025 | comparable sales | FY2025 | +5% – +7% | Raised |
| Aug 27, 2025 | Adjusted diluted income per common share | Q3 FY2025 | $0.12 – $0.24 | New |
| Aug 27, 2025 | Adjusted diluted income per common share | FY2025 | $4.76 – $5.16 | Raised |
| Aug 27, 2025 | Diluted income per common share | Q3 FY2025 | $0.09 – $0.21 | New |
| Aug 27, 2025 | Diluted income per common share | FY2025 | $4.56 – $4.96 | Raised |
| Aug 27, 2025 | Net income | Q3 FY2025 | $5.00M – $12.00M | New |
| Aug 27, 2025 | Adjusted net income | Q3 FY2025 | $7.00M – $13.00M | New |
| Aug 27, 2025 | Net income | FY2025 | $253.00M – $275.00M | Raised |
| Aug 27, 2025 | Adjusted net income | FY2025 | $264.00M – $286.00M | Raised |
| Aug 27, 2025 | Net sales | Q3 FY2025 | $950.00M – $970.00M | New |
| Aug 27, 2025 | Net sales | FY2025 | $4.44B – $4.52B | Raised |
| Jun 4, 2025 | Gross capital expenditures | FY2025 | $210.00M – $230.00M | Reaffirmed |
| Jun 4, 2025 | comparable sales | Q2 FY2025 | +7% – +9% | New |
| Jun 4, 2025 | comparable sales | FY2025 | +3% – +5% | New |
| Jun 4, 2025 | Adjusted diluted income per common share | Q2 FY2025 | $0.50 – $0.62 | New |
| Jun 4, 2025 | Adjusted diluted income per common share | FY2025 | $4.25 – $4.72 | Raised |
| Jun 4, 2025 | Diluted income per common share | Q2 FY2025 | $0.45 – $0.57 | New |
| Jun 4, 2025 | Diluted income per common share | FY2025 | $4.04 – $4.51 | Narrowed |
| Jun 4, 2025 | Net income | Q2 FY2025 | $25.00M – $32.00M | New |
| Jun 4, 2025 | Adjusted net income | Q2 FY2025 | $28.00M – $34.00M | New |
| Jun 4, 2025 | Net income | FY2025 | $223.00M – $249.00M | Narrowed |
| Jun 4, 2025 | Adjusted net income | FY2025 | $235.00M – $261.00M | Raised |
| Jun 4, 2025 | Net sales | Q2 FY2025 | $975.00M – $995.00M | New |
| Jun 4, 2025 | Net sales | FY2025 | $4.33B – $4.42B | Raised |
| Mar 19, 2025 | Gross capital expenditures | FY2025 | $210.00M – $230.00M | New |
| Mar 19, 2025 | Adjusted diluted income per common share | Q1 FY2025 | $0.50 – $0.61 | New |
| Mar 19, 2025 | Adjusted diluted income per common share | FY2025 | $4.10 – $4.72 | New |
| Mar 19, 2025 | Diluted income per common share | Q1 FY2025 | $0.44 – $0.55 | New |
| Mar 19, 2025 | Diluted income per common share | FY2025 | $3.90 – $4.52 | New |
| Mar 19, 2025 | Net income | Q1 FY2025 | $25.00M – $31.00M | New |
| Mar 19, 2025 | Adjusted net income | Q1 FY2025 | $28.00M – $34.00M | New |
| Mar 19, 2025 | Net income | FY2025 | $216.00M – $250.00M | New |
| Mar 19, 2025 | Adjusted net income | FY2025 | $227.00M – $261.00M | New |
| Mar 19, 2025 | Net sales | Q1 FY2025 | $905.00M – $925.00M | New |
| Mar 19, 2025 | Net sales | FY2025 | $4.21B – $4.33B | New |
| Dec 4, 2024 | Gross capital expenditures | FY2024 | $340.00M | Narrowed |
| Dec 4, 2024 | comparable sales | Q4 FY2024 | -5% – -3% | New |
| Dec 4, 2024 | comparable sales | FY2024 | -3% | Lowered |
| Dec 4, 2024 | Adjusted diluted income per common share | Q4 FY2024 | $3.23 – $3.41 | New |
| Dec 4, 2024 | Adjusted diluted income per common share | FY2024 | $4.78 – $4.96 | Raised |
| Dec 4, 2024 | Diluted income per common share | Q4 FY2024 | $3.15 – $3.33 | New |
| Dec 4, 2024 | Diluted income per common share | FY2024 | $4.34 – $4.52 | Raised |
| Dec 4, 2024 | Net income | Q4 FY2024 | $174.00M – $184.00M | New |
| Dec 4, 2024 | Adjusted net income | Q4 FY2024 | $179.00M – $189.00M | New |
| Dec 4, 2024 | Net income | FY2024 | $240.00M – $250.00M | Raised |
| Dec 4, 2024 | Adjusted net income | FY2024 | $265.00M – $275.00M | Raised |
| Dec 4, 2024 | Net sales | Q4 FY2024 | $1.35B – $1.38B | New |
| Dec 4, 2024 | Net sales | FY2024 | $3.84B – $3.87B | Raised |
| Aug 28, 2024 | Gross capital expenditures | FY2024 | $335.00M – $345.00M | Lowered |
| Aug 28, 2024 | comparable sales | FY2024 | +4% – +5.5% | New |
| Aug 28, 2024 | Adjusted diluted income per common share | Q3 FY2024 | $0.10 – $0.22 | New |
| Aug 28, 2024 | Adjusted diluted income per common share | FY2024 | $4.35 – $4.71 | Lowered |
| Aug 28, 2024 | Diluted loss per common share | Q3 FY2024 | $0.04 – $0.24 | New |
| Aug 28, 2024 | Diluted income per common share | FY2024 | $3.98 – $4.41 | Lowered |
| Aug 28, 2024 | Net loss | Q3 FY2024 | $2.00M – $13.00M | New |
| Aug 28, 2024 | Adjusted net income | Q3 FY2024 | $5.00M – $12.00M | New |
| Aug 28, 2024 | Net income | FY2024 | $220.00M – $244.00M | Lowered |
| Aug 28, 2024 | Adjusted net income | FY2024 | $241.00M – $261.00M | Lowered |
| Aug 28, 2024 | Net sales | Q3 FY2024 | $780.00M – $800.00M | New |
| Aug 28, 2024 | Net sales | FY2024 | $3.73B – $3.80B | New |
| Jun 5, 2024 | Gross capital expenditures | FY2024 | $345.00M – $355.00M | New |
| Jun 5, 2024 | adjusted diluted income per common share | FY2024 | $5.00 – $5.40 | New |
| Jun 5, 2024 | Diluted income per common share | Q2 FY2024 | $0.57 – $0.69 | New |
| Jun 5, 2024 | Diluted income per common share | FY2024 | $4.97 – $5.37 | Lowered |
| Jun 5, 2024 | Net income | Q2 FY2024 | $32.00M – $38.00M | New |
| Jun 5, 2024 | Net income | FY2024 | $275.00M – $297.00M | Lowered |
| Jun 5, 2024 | adjusted net income | FY2024 | $277.00M – $299.00M | New |
| Jun 5, 2024 | Net sales | Q2 FY2024 | $830.00M – $850.00M | New |
| Jun 5, 2024 | Net sales | FY2024 | $3.79B – $3.87B | Lowered |
| Mar 20, 2024 | Gross capital expenditures | FY2024 | $365.00M | New |
| Mar 20, 2024 | Diluted income per common share | Q1 FY2024 | $0.58 – $0.69 | New |
| Mar 20, 2024 | Diluted income per common share | FY2024 | $5.71 – $6.22 | New |
| Mar 20, 2024 | Net income | Q1 FY2024 | $32.00M – $38.00M | New |
| Mar 20, 2024 | Net income | FY2024 | $318.00M – $346.00M | New |
| Mar 20, 2024 | Net sales | Q1 FY2024 | $826.00M – $846.00M | New |
| Mar 20, 2024 | Net sales | FY2024 | $3.97B – $4.07B | New |
| Nov 29, 2023 | Gross capital expenditures | FY2023 | $335.00M | New |
| Nov 29, 2023 | comparable sales | Q4 FY2023 | +2% – +3% | New |
| Nov 29, 2023 | comparable sales | FY2023 | +2.5% | Narrowed |
| Nov 29, 2023 | Diluted income per common share | Q4 FY2023 | $3.64 – $3.80 | New |
| Nov 29, 2023 | Diluted income per common share | FY2023 | $5.40 – $5.56 | Raised |
| Nov 29, 2023 | Net income | Q4 FY2023 | $201.00M – $211.00M | New |
| Nov 29, 2023 | Net income | FY2023 | $300.00M – $310.00M | Narrowed |
| Nov 29, 2023 | Net sales | Q4 FY2023 | $1.32B – $1.35B | New |
| Nov 29, 2023 | Net sales | FY2023 | $3.54B – $3.57B | New |
| Aug 30, 2023 | Gross capital expenditures | FY2023 | $335.00M | Reaffirmed |
| Aug 30, 2023 | comparable sales | FY2023 | +1% – +3% | Reaffirmed |
| Aug 30, 2023 | Diluted income per common share | Q3 FY2023 | $0.17 – $0.25 | New |
| Aug 30, 2023 | Diluted income per common share | FY2023 | $5.27 – $5.55 | Narrowed |
| Aug 30, 2023 | Net income | Q3 FY2023 | $10.00M – $14.00M | New |
| Aug 30, 2023 | Net income | FY2023 | $295.00M – $311.00M | Lowered |
| Aug 30, 2023 | Net sales | Q3 FY2023 | $715.00M – $730.00M | New |
| Aug 30, 2023 | Net sales | FY2023 | $3.50B – $3.57B | Reaffirmed |
| Jun 1, 2023 | Gross capital expenditures | FY2023 | $335.00M | Raised |
| Jun 1, 2023 | comparable sales | Q2 FY2023 | +2% – +3% | New |
| Jun 1, 2023 | comparable sales | FY2023 | +1% – +3% | Lowered |
| Jun 1, 2023 | Diluted income per common share | Q2 FY2023 | $0.80 – $0.85 | New |
| Jun 1, 2023 | Diluted income per common share | FY2023 | $5.31 – $5.71 | New |
| Jun 1, 2023 | Net income | Q2 FY2023 | $44.00M – $48.00M | New |
| Jun 1, 2023 | Net income | FY2023 | $297.00M – $319.00M | New |
| Jun 1, 2023 | Net sales | Q2 FY2023 | $755.00M – $765.00M | New |
| Jun 1, 2023 | Net sales | FY2023 | $3.50B – $3.57B | Narrowed |
| Mar 15, 2023 | Gross capital expenditures | FY2023 | $325.00M | New |
| Mar 15, 2023 | comparable sales | Q1 FY2023 | +2.5% – +4% | New |
| Mar 15, 2023 | comparable sales | FY2023 | +1% – +4% | New |
| Mar 15, 2023 | Diluted income per common share | Q1 FY2023 | $0.59 – $0.65 | New |
| Mar 15, 2023 | Diluted income per common share | FY2023 | $5.25 – $5.76 | New |
| Mar 15, 2023 | Net income | Q1 FY2023 | $33.00M – $37.00M | New |
| Mar 15, 2023 | Net income | FY2023 | $295.00M – $323.00M | New |
| Mar 15, 2023 | Net sales | Q1 FY2023 | $723.00M – $735.00M | New |
| Mar 15, 2023 | Net sales | FY2023 | $3.49B – $3.59B | New |
| Nov 30, 2022 | Gross capital expenditures | FY2022 | $235.00M | Raised |
| Nov 30, 2022 | Diluted income per common share | Q4 FY2022 | $2.93 – $3.09 | New |
| Nov 30, 2022 | Diluted income per common share | FY2022 | $4.55 – $4.71 | New |
| Nov 30, 2022 | Net income | Q4 FY2022 | $164.00M – $173.00M | New |
| Nov 30, 2022 | Net income | FY2022 | $254.00M – $263.00M | New |
| Nov 30, 2022 | Net sales | Q4 FY2022 | $1.09B – $1.11B | New |
| Nov 30, 2022 | Net sales | FY2022 | $3.04B – $3.06B | New |
| Aug 31, 2022 | Gross capital expenditures | FY2022 | $235.00M | New |
| Aug 31, 2022 | comparable sales | Q3 FY2022 | +7% – +9% | New |
| Aug 31, 2022 | comparable sales | FY2022 | +3% – +5% | New |
| Aug 31, 2022 | Diluted income per common share | Q3 FY2022 | $0.08 – $0.19 | New |
| Aug 31, 2022 | Diluted income per common share | FY2022 | $4.26 – $4.56 | Lowered |
| Aug 31, 2022 | Net income | Q3 FY2022 | $4.00M – $11.00M | New |
| Aug 31, 2022 | Net income | FY2022 | $238.00M – $255.00M | Lowered |
| Aug 31, 2022 | Net sales | Q3 FY2022 | $600.00M – $619.00M | New |
| Aug 31, 2022 | Net sales | FY2022 | $2.97B – $3.02B | Lowered |
| Jun 8, 2022 | Gross capital expenditures | FY2022 | $225.00M | New |
| Jun 8, 2022 | Diluted income per common share | Q2 FY2022 | $0.74 – $0.86 | New |
| Jun 8, 2022 | Diluted income per common share | FY2022 | $4.85 – $5.24 | Lowered |
| Jun 8, 2022 | Net income | Q2 FY2022 | $41.00M – $48.00M | New |
| Jun 8, 2022 | Net income | FY2022 | $271.00M – $293.00M | Lowered |
| Jun 8, 2022 | Net sales | Q2 FY2022 | $675.00M – $695.00M | New |
| Jun 8, 2022 | Net sales | FY2022 | $3.04B – $3.12B | Lowered |
| Mar 30, 2022 | Diluted income per common share | Q1 FY2022 | $0.54 – $0.62 | New |
| Mar 30, 2022 | Diluted income per common share | FY2022 | $5.19 – $5.70 | New |
| Mar 30, 2022 | Net income | Q1 FY2022 | $30.00M – $35.00M | New |
| Mar 30, 2022 | Net income | FY2022 | $292.00M – $320.00M | New |
| Mar 30, 2022 | Net sales | Q1 FY2022 | $644.00M – $658.00M | New |
| Mar 30, 2022 | Net sales | FY2022 | $3.16B – $3.26B | New |
| Dec 1, 2021 | comparable sales | Q4 FY2021 | +2% – +4% | New |
| Dec 1, 2021 | comparable sales | FY2021 | +30% | New |
| Dec 1, 2021 | Diluted income per common share | Q4 FY2021 | $2.36 – $2.48 | New |
| Dec 1, 2021 | Diluted income per common share | FY2021 | $4.82 – $4.94 | New |
| Dec 1, 2021 | Net income | Q4 FY2021 | $133.00M – $140.00M | New |
| Dec 1, 2021 | Net income | FY2021 | $272.00M – $279.00M | New |
| Dec 1, 2021 | Net sales | Q4 FY2021 | $985.00M – $1.01B | New |
| Dec 1, 2021 | Net sales | FY2021 | $2.84B – $2.86B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Five Below filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Results
- Results
- Update
- Results
- Update
- Results
- Results
- Results
- Update
- Results
- Update
- Results
- Update